title: Hyperammonemic encephalopathy after adjunction of phenobarbital to chronic topiramate and oxcarbazepine therapy.
authors.affiliation: Department of Intensive Care, Cliniques St-Luc, Université catholique de Louvain, Avenue Hippocrate, 10, 1200, Brussels, Belgium. philippe.hantson@uclouvain.be.
authors.forename: Philippe
authors.initials: P
authors.lastname: Hantson
authors.affiliation: Department of Neurology, Centre Neurologique William Lennox, Ottignies, Belgium.
authors.forename: Anne
authors.initials: A
authors.lastname: Frederick
authors.affiliation: Reference Centre for Refractory Epilepsy, Cliniques St-Luc, Université catholique de Louvain, Brussels, Belgium.
authors.forename: Kenou
authors.initials: K
authors.lastname: van Rijckevorsel
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use*; D001927:Brain Diseases / Q000188:drug therapy* / Q000209:etiology*; D002220:Carbamazepine / Q000031:analogs & derivatives / Q000627:therapeutic use; D002648:Child; D004569:Electroencephalography; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D022124:Hyperammonemia / Q000150:complications* / Q000188:drug therapy*; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D000078330:Oxcarbazepine; D010634:Phenobarbital / Q000627:therapeutic use; D000077236:Topiramate
chemical_list: D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D000077236:Topiramate; D005632:Fructose; D002220:Carbamazepine; D000078330:Oxcarbazepine; D010634:Phenobarbital